RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 February 2009 | By

On 18 December 2008, the European Medicines Agency (EMEA) published its proposed policy for making public the agency's documents. Comments on the proposed policy are due by 2 March 2009. The policy's scope extends to human and veterinary medicinal products. The policy does not apply to working documents, only documents where the decision-making process has been concluded. It includes a provision for redacting documents for the protection of confidentiality and personal data. EMEA proposes implementing the public access policy in two phases. The first phase concentrates on adequate follow-up to written requests for access to documents. The second phase includes the gradual population of an electronic registry of EMEA documents on the agency's website.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.